← Back to catalogue

Lyra

FDA UDI

Class II (US FDA UDI)

by Quidel Corp.

Identity

Trade Name
Lyra FDA UDI
Generic Name
Multiple Human herpesvirus nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Lyra Direct HSV 1+2/VZV Assay FDA UDI
Model / Reference
Direct HSV 1+2/VZV Assay FDA UDI
Description
Lyra Direct HSV 1+2/VZV Assay FDA UDI

Identifiers

Catalog Number
M102 FDA UDI
Primary DI / UDI-DI
30014613311027 FDA UDI
FDA Product Code
PGI FDA UDI
GMDN Term
Multiple Human herpesvirus nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3309 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple Human herpesvirus nucleic acid IVD, kit, nucleic acid technique (NAT)

Lyra by Quidel Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple Human herpesvirus nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Quidel Corp.

Sources (1)

  • FDA UDI 13fbb4c1-d880-453e-9394-f3a81150e944 36 fields · synced Jun 8, 2026